Valeria Grancini
Overview
Explore the profile of Valeria Grancini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Grancini V, Gramegna A, Zazzeron L, Alicandro G, Porcaro L, Piedepalumbo F, et al.
Diabetes Metab
. 2023 Aug;
49(5):101466.
PMID: 37536552
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a group of new drugs for the treatment of cystic fibrosis (CF) and elexacaftor + tezacaftor + ivacaftor (ETI) triple combination therapy...
12.
Panico C, Bonora B, Camera A, Chilelli N, Prato G, Favacchio G, et al.
Cardiovasc Diabetol
. 2023 Jun;
22(1):164.
PMID: 37391739
In recent years, GLP-1 receptor agonists (GLP-1RA), and SGLT-2 inhibitors (SGLT-2i) have become available, which have become valuable additions to therapy for type 2 diabetes as they are associated with...
13.
Grancini V, Vianello F, Colosimo S, Gaglio A, Resi V, Arosio M, et al.
Front Pediatr
. 2022 Jun;
10:882319.
PMID: 35712621
We report the case of a 3-year-old girl admitted to her town emergency department for fever (39°C) associated with diarrhea, generalized edema, oliguria, and drowsiness. The blood test revealed metabolic...
14.
Grancini V, Resi V, Palmieri E, Pugliese G, Orsi E
Pharmacol Res
. 2019 Jan;
141:556-573.
PMID: 30690071
Diabetes is a common feature in cirrhotic individuals both before and after liver transplantation and negatively affects prognosis. Certain aetiological agents of chronic liver disease and loss of liver function...
15.
Grancini V, Trombetta M, Lunati M, Boselli M, Gatti S, Donato M, et al.
J Hepatol
. 2019 Jan;
70(5):954-962.
PMID: 30677460
Background & Aims: Diabetes occurring as a direct consequence of loss of liver function is usually characterized by non-diabetic fasting plasma glucose (FPG) and haemoglobin A (HbA) levels and should...
16.
Lunati M, Bedeschi M, Resi V, Grancini V, Palmieri E, Salera S, et al.
PLoS One
. 2017 Oct;
12(10):e0185371.
PMID: 29053727
Objective: The Williams-Beuren syndrome (WS) is associated with impaired glucose metabolism (IGM) early in adulthood. However, the pathophysiology of IGM remains poorly defined, due to the lack of longitudinal studies...
17.
Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G
Liver Int
. 2016 Dec;
37(7):950-962.
PMID: 27943508
By definition, hepatogenous diabetes is directly caused by loss of liver function, implying that it develops after cirrhosis onset. Therefore, it should be distinguished from type 2 diabetes developing before...
18.
Lunati M, Grancini V, Colombo C, Palmieri E, Resi V, Perrino M, et al.
Metabolism
. 2015 Dec;
65(1):1-6.
PMID: 26683791
Background And Aims: The administration of Liraglutide, a long-acting GLP-1 receptor (GLP-1R) agonist, is associated with C-cell adenomas and carcinomas in rats. In humans, GLP-1R is highly expressed in C-cells...
19.
Iurlo A, Orsi E, Cattaneo D, Resi V, Bucelli C, Orofino N, et al.
Oncotarget
. 2015 Sep;
6(32):33944-51.
PMID: 26376678
Background: Tyrosine kinase inhibitors (TKIs) have dramatically changed the prognosis of patients with chronic myeloid leukemia (CML). They have a distinct toxicity profile that includes glycometabolic alterations: i.e. diabetes mellitus...
20.
Grancini V, Trombetta M, Lunati M, Zimbalatti D, Boselli M, Gatti S, et al.
J Hepatol
. 2015 Aug;
63(6):1484-90.
PMID: 26297917
Background & Aims: This study evaluated the contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes. Methods: One-hundred and sixty cirrhotic patients with normal fasting plasma glucose (FPG), three...